Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 3, 2007, Pages 375-378

  Inda, Ana M ^a   Andrini, L B ^a   Garcia, M N ^a   Garcia A L ^a   Fernandez Blanco A ^a   Furnus, C C ^a   Galletti, S M ^a   Prat, G D ^a   Errecalde, A L ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Adenocarcinoma; Angiogenesis; CD34; Epidermoid carcinoma; Lung cancer; VEGF

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, CD34; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35348889515     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Folkman J., Watson K., Ingiber D., Hanahan D.: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond). 339: 58-61, 1981.
2. Mattern J., Koomägi R., Volm M.: Association of VEGF expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. British Journal of Cancer. 73: 931-4, 1996.
3. Mineo T., Ambrogi V., Baldi A., et al.: Prognostic impact of VEGF, CD31, CD34 and CD105 expression and tumour vessel invasion after radical surgery for IB-II A non-small cell lung cancer. J. Clin. Pathol. 57: 591-7, 2004.
4. Tanno S., Ohsaki Y., Nakanishi K., Toyoshima E., Kikuchi K.: Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer. 46: 11-9, 2004.
5. Shepherd F., Sridhar S.: Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer. 41: 63-72, 2003.
6. Weidner N., Semple J., Welch W., Folkman J.: Tumor angiogenesis and metastasis correlation and invasive breast carcinoma. N. Engl. J. Med. 324: 1-8, 1991.
7. Chandrachud L., Pendleton N., Chisholm D., Horan M., Schor A.: Relationship between vascularity, age and survival in non-small cell lung cancer. Br. J. Cancer. 76: 1367-75, 1997.
8. Pastorino V., Andreola S., Tagliabue E., et al.: Immmunocytochemical markers in stage I lung cancer: Relevance to prognosis. J. Clin. Oncol. 15: 2858-65, 1997.
9. Vermeulen P., Gasparini G., Fox P., et al.: Quantification of angiogenesis in solid human tumors: an international consensus on methodology and criteria of evaluation. Eur. J. Cancer. 32 A: 2474-84, 1996.
10. Tannock I.F.: The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor. Br. J. Cancer. 22: 258-73, 1968.
11. Ushijima C.H., Tsukamoto S., Yamazaki K., Yoshino I., Sugio K., Sugimachi K.: High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer. 34: 233-41, 2001.
12. Ghio P., Cappia S., Selvaggi G., et al.: Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cells lung cancer. Clin. Lung Cancer. 7: 395-400, 2006.
13. Nakashima T., Huang C.L., Liu D. et al. : Expression of vascular endothelial growth factor - A and vascular endothelial growth factor - C as prognostic factors for non-small cell lung cancer. Med. Sci. Monit. 10: 157-65, 2004.
14. Fox S., Gatter K., Bicknell R., et al.: Relationship of endothelial cell proliferation of tumor vascularity in human breast cancer. Cancer Res. 53: 4161-63, 1993.
15. Vartanian R.K., Weidner N.: Correlation of intratumoral endothelial cell proliferation with microvessel density tumor angiogenesis and tumor cell proliferation in breast carcinoma. Am. J. Pathol. 144: 1188-94, 1994.
16. Porschen R., Classen S., Pointek M., Borchard F.: Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res. 54: 587-91, 1994.
17. Yano T., Tanikawa S., Fujie T.: Vascular endothelial growth factor expression and neovascularization in non-small cell lung cancer. Eur. J. Cancer. 36: 601-9, 2000.
18. Mineo T.C., Ambrogi V., Baldi A., et al.: Prognostic impact of VEGF, CD31, CD34, and CD 105 expression and tumour vessel invasion after radical surgery for IB - IIA non-small cell lung cancer. J. Clin. Pathol. 6: 591-7, 2004.
19. Kojima H., Shijubo N., Yamada G., et al.: Clinical significance of vascular endothelial growth factor - C and vascular endotelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer 8: 1668-77, 2005.